Stemtech annual free cash flow
2012
2013
2014
2016
2017
2020
2023
2024
2025
Stemtech Free Cash Flow (FCF) History (STEK)
Stemtech reported −$483,583 in free cash flow for fiscal 2025, an increase of $117,615 from the previous fiscal year, with a free cash flow margin of −16.81%.
View full Stemtech company overviewStemtech free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$483,583 | $117,615 | — | −16.81% |
| 2024 | 2024-12-31 | −$601,198 | $1.4M | — | −11.90% |
| 2023 | 2023-12-31 | −$2.0M | — | — | −41.37% |
| 2020 · Dec 31 | 2020-12-31 | −$278,315 | — | — | −6.35% |
| 2017 | 2017-08-31 | −$35,085 | $2,550 | — | — |
| 2016 | 2016-08-31 | −$37,635 | — | — | — |
| 2014 | 2014-08-31 | −$31,687 | $5,148 | — | — |
| 2013 | 2013-08-31 | −$36,835 | −$16,986 | — | — |
| 2012 | 2012-08-31 | −$19,849 | — | — | — |
Stemtech quarterly free cash flow
Q1.13
Q3.13
Q1.14
Q3.14
Q1.15
Q2.15
Q1.17
Q2.17
Q3.17
Q4.17
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$54,844 | −$129,796 | — | −8.71% |
| Q1 2026 | 2026-03-31 | −$425,883 | $284,624 | — | −91.99% |
| Q4 2025 | 2025-12-31 | $127,001 | $397,921 | — | +27.72% |
| Q3 2025 | 2025-09-30 | $24,971 | $1.2M | — | +2.93% |
| Q2 2025 | 2025-06-30 | $74,952 | $251,310 | — | +10.74% |
| Q1 2025 | 2025-03-31 | −$710,507 | −$1.7M | — | −81.85% |
| Q4 2024 | 2024-12-31 | −$270,920 | — | — | −20.62% |
| Q3 2024 | 2024-09-30 | −$1.2M | — | — | −113.55% |
| Q2 2024 | 2024-06-30 | −$176,358 | — | — | −13.30% |
| Q1 2024 | 2024-03-31 | $1.0M | — | — | +73.59% |
| Q4 2017 | 2017-08-31 | −$6,045 | — | — | — |
| Q3 2017 | 2017-05-31 | −$6,992 | — | — | — |
| Q2 2017 | 2017-02-28 | −$15,647 | — | — | — |
| Q1 2017 | 2016-11-30 | −$6,401 | — | — | — |
| Q2 2015 | 2015-02-28 | −$3,248 | — | — | — |
| Q1 2015 | 2014-11-30 | −$10,911 | $5,385 | — | — |
| Q3 2014 | 2014-05-31 | −$2,913 | $8,749 | — | — |
| Q1 2014 | 2013-11-30 | −$16,296 | −$16,296 | — | — |
| Q3 2013 | 2013-05-31 | −$11,662 | — | — | — |
| Q1 2013 | 2012-11-30 | $0 | — | — | — |
Stemtech free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$278,315 to −$483,583, a net decrease of $205,268. Stemtech's latest reported quarter, Q2 2026, generated −$54,844 in free cash flow, a decrease of $129,796 year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Stemtech source filings ↗